Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Gynecologic Oncology
|
May 27, 2026
Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma
Cassidy S Abdeen, Reed M O'Connor, Julia Chalif, et al.
Gynecologic Oncology
|
February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Gynecologic Oncology
|
January 29, 2023
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population
Paulina J Haight, David A Barrington, Stephen M Graves, et al.
Cell Death and Differentiation
|
April 18, 2015
Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio
M Itsumi, S Inoue, A J Elia, et al.
Gynecologic Oncology
|
August 15, 2025
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Bradley R Corr, Samantha M Thomas, Paulina J Haight, et al.
Gynecologic Oncology Reports
|
July 7, 2023
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population
Paulina J Haight, Rachael N Piver, David A Barrington, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Gynecologic Oncology
|
May 27, 2026
Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma
Cassidy S Abdeen, Reed M O'Connor, Julia Chalif, et al.
Gynecologic Oncology
|
February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Gynecologic Oncology
|
January 29, 2023
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population
Paulina J Haight, David A Barrington, Stephen M Graves, et al.
Cell Death and Differentiation
|
April 18, 2015
Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio
M Itsumi, S Inoue, A J Elia, et al.
Gynecologic Oncology
|
August 15, 2025
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Bradley R Corr, Samantha M Thomas, Paulina J Haight, et al.
Gynecologic Oncology Reports
|
July 7, 2023
Assessment of the feasibility of same-day discharge following minimally invasive hysterectomy in the elderly population
Paulina J Haight, Rachael N Piver, David A Barrington, et al.
Page
of 8